1) Strong Start to 2026
- The company reported over $10 billion in net revenues for Q1 2026, a 9% increase YoY, with 2.7% organic growth. - Adjusted operating income (OI) grew by 10% to $4.2 billion, with a 10% increase in adjusted gross profit to $6.9 billion. - Adjusted diluted earnings per share (EPS) rose 16% to $1.96, benefiting from a $0.18 currency tailwind.

2) International Smoke-Free Business Performance
- The international smoke-free segment delivered double-digit volume growth and mid-teens organic revenue growth, primarily driven by IQOS. - IQOS achieved 11% adjusted in-market sales growth, with gross margins exceeding 70%, reflecting strong pricing and operational efficiencies. - The overall smoke-free business saw 5.3% organic net revenue growth despite challenges in the U.S. market.

3) Challenges in U.S. Market
- The U.S. segment faced headwinds, including a 10% decline in ZYN shipments due to inventory normalization and increased promotional activities. - Cigarette volumes declined at a higher rate than expected, influenced by prior year comparisons and economic pressures. - The company anticipates a gradual improvement in U.S. performance as comparisons normalize and new product innovations are launched.

4) Operational and Product Innovations
- The company is investing in future growth with plans to launch ZYN Innovations and expand its smoke-free portfolio. - IQOS is set to launch new products, including IQOS ILUMA, which has received FDA reauthorization as a modified risk tobacco product. - The company is also focused on expanding its multi-category portfolio, with significant growth in VEEV and ZYN, aiming to capture more market share.

5) Guidance and Outlook
- The company reaffirms its guidance for 2026, expecting organic net revenue growth of 5% to 7% and adjusted diluted EPS growth of 7.5% to 9.5%. - The outlook remains cautious due to macroeconomic uncertainties, but confidence is bolstered by strong Q1 performance and ongoing investments in smoke-free products. - The transcript lacks specific details on the anticipated impact of regulatory changes on the nicotine pouch market.

Bottom line: The company's strong Q1 results highlight its robust growth in the smoke-free segment, despite challenges in the U.S. market. Continued investment in innovation and a focus on pricing power position PM well for sustained growth, making it an attractive prospect for shareholders.